Topical Collection on Immuno-oncology

ISSN: 1523-3790 (Print) 1534-6269 (Online)

In this topical collection (13 articles)

  1. Immuno-oncology (RM Bukowski and JH Finke, Section Editors)

    Alternative Checkpoints as Targets for Immunotherapy

    Ayush Pant, Ravi Medikonda, Michael Lim Article:126
    Download PDF (387KB) View Article

  2. No Access

    Immuno-oncology (RM Bukowski and JH Finke, Section Editors)

    Immune Response Evaluation and Treatment with Immune Checkpoint Inhibitors Beyond Clinical Progression: Response Assessments for Cancer Immunotherapy

    Sirisha L. Mushti, Flora Mulkey, Shenghui Tang, Harpreet Singh… Article:116

  3. No Access

    Immuno-oncology (RM Bukowski and JH Finke, Section Editors)

    Cytokines: Signalling Improved Immunotherapy?

    Alana J. De Luca, A. Bruce Lyons, Andrew S. Flies Article:103

  4. Immuno-oncology (RM Bukowski and JH Finke, Section Editors)

    Immunology of Lynch Syndrome

    Danielle M. Pastor, Jeffrey Schlom Article:96
    Download PDF (7748KB) View Article

  5. No Access

    Immuno-oncology (RM Bukowski and JH Finke, Section Editors)

    Spectrum and Clinical Activity of PD-1/PD-L1 Inhibitors: Regulatory Approval and Under Development

    Leandro Jonata Carvalho Oliveira, Aline Bobato Lara Gongora… Article:70

  6. Immuno-oncology (RM Bukowski and JH Finke, Section Editors)

    Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors

    Flora Pirozzi, Remo Poto, Luisa Aran, Alessandra Cuomo… Article:13
    Download PDF (947KB) View Article

  7. No Access

    Immuno-oncology (RM Bukowski and JH Finke, Section Editors)

    Development of Delivery Systems for Local Administration of Cytokines/Cytokine Gene-Directed Therapeutics: Modern Oncologic Implications

    Jhalak Dholakia, Alexander C. Cohen, Charles A. Leath III… Pages 389-397

  8. No Access

    Immuno-oncology (RM Bukowski and JH Finke, Section Editors)

    New Checkpoint Inhibitors on the Road: Targeting TIM-3 in Solid Tumors

    Ana Luiza Gomes de Morais, Sara Cerdá, Maria de Miguel Pages 651-658

  9. No Access

    Immuno-oncology (RM Bukowski and JH Finke, Section Editors)

    Fatty Acid Metabolism and Cancer Immunotherapy

    Yuting Luo, Hanbing Wang, Baorui Liu, Jia Wei Pages 659-670

  10. No Access

    Immuno-oncology (RM Bukowski and JH Finke, Section Editors)

    Current Clinical Trial Landscape of OX40 Agonists

    Rashi Yadav, William L. Redmond Pages 951-960

  11. No Access

    Immuno-oncology (RM Bukowski and JH Finke, Section Editors)

    Immune Checkpoint Inhibitor Rechallenge and Resumption: a Systematic Review

    Caroline Plazy, Dalil Hannani, Elisa Gobbini Pages 1095-1106

  12. No Access

    Immuno-oncology (RM Bukowski and JH Finke, Section Editors)

    Clinical Development of Anti-TIGIT Antibodies for Immunotherapy of Cancer

    Vaia Florou, Ignacio Garrido-Laguna Pages 1107-1112

  13. Review

    Immune Priming with Spatially Fractionated Radiation Therapy

    Lauren Lukas, Hualin Zhang, Karen Cheng, Alan Epstein Pages 1483-1496
    Download PDF (1171KB) View Article